[29P] 情報伝達

8:30 〜 15:00

[29P-143] The fourth-generation EGFR inhibitor BLU-945 overcomes cancer multidrug resistance by inhibiting the drug efflux activity of ABCG2

○Chung-Pu Wu^1,2,3,4, Bing-Huan Lin¹, Yen-Ching Li¹, Megumi Murakami⁵, Suresh V Ambudkar⁵ (1. Graduate Institute of Biomedical Sciences, Chang Gung University, 2. Department of Physiology and Pharmacology, Chang Gung University, 3. Department of Obstetrics and Gynecology, Taipei Chang Gung Memorial Hospital, 4. Molecular Medicine Research Center, College of Medicine, Chang Gung University, 5. Laboratory of Cell Biology, CCR, NCI, National Institutes of Health)

閲覧にはパスワードが必要です

要旨の閲覧にはパスワードが必要です。パスワードを入力してください。
参加申込を完了された方にはパスワードをメールにて配信いたします。